Beta-adrenergic blockade in diuretic-treated patients with essential hypertension
- PMID: 234005
- DOI: 10.1056/NEJM197501092920203
Beta-adrenergic blockade in diuretic-treated patients with essential hypertension
Abstract
The influence of beta-adrenergic blockade (160 mg per day of propranolol for four weeks) on plasma renin activity, plasma volume, and arterial pressure was explored in 20 patients with essential hypertension with hyper-reninemia from long-term diuretic therapy. In 15 of these patients renin activity remained elevated (range, 3.1 to 23.0 ng per milliliter). Plasma volume was unchanged in eight, increased in 11 and reduced in one. In 17 subjects mean arterial pressure decreased by more than 10 mm Hg, but these impressive reductions could not be explained by quantitative changes in either renin activity (r equals 0.1) or plasma volume (r equals 0.1). These data suggest that suppression of plasma renin activity by beta-adrenergic blockade is not attainable during diuretic therapy and is not the major factor responsible for the antihypertensive action of propranolol.
Similar articles
-
[Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].Schweiz Med Wochenschr. 1977 Jan 29;107(4):104-15. Schweiz Med Wochenschr. 1977. PMID: 834983 Clinical Trial. German.
-
Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.Postgrad Med J. 1983;59 Suppl 3(689):140-58. Postgrad Med J. 1983. PMID: 6139800 Free PMC article. Review.
-
Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.N Engl J Med. 1976 Jul 8;295(2):68-73. doi: 10.1056/NEJM197607082950203. N Engl J Med. 1976. PMID: 775330 Clinical Trial.
-
[Measurement of plasma renin activity, blood volume and exchangeable sodium: an aid in the orientation of treatment of essential arterial hypertension].Sem Hop. 1977 May 23;53(20):1147-53. Sem Hop. 1977. PMID: 20666 French.
-
Haemodynamic effects of propranolol in hypertension: a review.Postgrad Med J. 1976;52 Suppl 4:92-100. Postgrad Med J. 1976. PMID: 787955 Review.
Cited by
-
Time course of blood pressure, pulse rate, plasma renin and metoprolol during treatment of hypertensive patients.Eur J Clin Pharmacol. 1980 May;17(5):321-8. doi: 10.1007/BF00558443. Eur J Clin Pharmacol. 1980. PMID: 6998708
-
Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil.Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):355-60. doi: 10.1007/BF00606548. Eur J Clin Pharmacol. 1976. PMID: 971700
-
Blockade of cardiac and renal beta-receptors by low dose propranolol in normal subjects. Clues to its antihypertensive effect.Br Heart J. 1979 Mar;41(3):331-5. doi: 10.1136/hrt.41.3.331. Br Heart J. 1979. PMID: 34409 Free PMC article. No abstract available.
-
Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.Klin Wochenschr. 1980 Oct 1;58(19):1071-89. doi: 10.1007/BF01476878. Klin Wochenschr. 1980. PMID: 7453095
-
Hypertension: which beta-blocker?Drugs. 1976 Dec;12(6):412-14. doi: 10.2165/00003495-197612060-00002. Drugs. 1976. PMID: 11985 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources